Cumulative incidence of cancer after solid organ transplantation-Reference-Cited by-同舟云学术

Cumulative incidence of cancer after solid organ transplantation

Published:2013-04-04 Issue:12 Volume:119 Page:2300-2308
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Hall Erin C.¹²,Pfeiffer Ruth M.¹,Segev Dorry L.²,Engels Eric A.¹

Affiliation:

1. Division of Cancer Epidemiology and Genetics; National Cancer Institute; Rockville Maryland

2. Department of Surgery; Johns Hopkins School of Medicine; Baltimore Maryland

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference34 articles.

1. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis;Grulich;Lancet.,2007

2. Annual Report of the US Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1998-2007. Rockville, MD: US Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau;Department of Health and Human Services, Health Resources and Services Administration;Division of Transplantation,2008

3. Competing risk regression models for epidemiologic data;Lau;Am J Epidemiol.,2009

4. Evaluating health outcomes in the presence of competing risks: a review of statistical methods and clinical applications;Varadhan;Med Care.,2010

Cited by 142 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Malignancies After Lung Transplantation;Transplant International;2024-09-09

2. Malignancies After Heart Transplantation;Transplant International;2024-09-09

3. Cancer Screening in Renal Transplant Recipients: Real-World Data;World Journal of Oncology;2024-08

4. Cancer Surveillance in Solid Organ Transplant Recipients With a Pretransplant History of Malignancy: Multidisciplinary Collaborative Expert Opinion;Transplantation;2024-05-21

5. Lactobacillus rhamnosus HN001 facilitates the efficacy of dual PI3K/mTOR inhibition prolonging cardiac transplant survival and enhancing antitumor effect;Microbiology Spectrum;2024-05-02